| Normal-weight obesity: implications for cardiovascular health N Jean, VK Somers, O Sochor, J Medina-Inojosa, EM Llano, ... Current atherosclerosis reports 16, 1-8, 2014 | 75 | 2014 |
| The obesity paradox and survivors of ischemic stroke P Wohlfahrt, F Lopez-Jimenez, A Krajcoviechova, M Jozifova, O Mayer, ... Journal of Stroke and Cerebrovascular Diseases 24 (6), 1443-1450, 2015 | 58 | 2015 |
| Mechanisms of adverse cardiometabolic consequences of obesity CM Diaz-Melean, VK Somers, JP Rodriguez-Escudero, P Singh, ... Current atherosclerosis reports 15, 1-10, 2013 | 42 | 2013 |
| Systematic review with meta-analysis: safety and effectiveness of combining biologics and small molecules in inflammatory bowel disease QA Alayo, M Fenster, O Altayar, KL Glassner, E Llano, K Clark-Snustad, ... Crohn's & Colitis 360 4 (1), otac002, 2022 | 37 | 2022 |
| Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies CC Frohne, EM Llano, A Perkovic, RD Cohen, JJ Luke Journal for ImmunoTherapy of Cancer 7, 1-6, 2019 | 34 | 2019 |
| SCGN deficiency results in colitis susceptibility LF Sifuentes-Dominguez, H Li, E Llano, Z Liu, A Singla, AS Patel, ... Elife 8, e49910, 2019 | 22 | 2019 |
| Outcomes of endoscopic treatment of leaks and fistulae after sleeve gastrectomy: results from a large multicenter US cohort ZL Smith, KH Park, EM Llano, K Donboli, L Fayad, S Han, L Kang, ... Surgery for Obesity and Related Diseases 15 (6), 850-855, 2019 | 20 | 2019 |
| Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis SJ Taylor, MG Winter, CC Gillis, LA Silva, AL Dobbins, MK Muramatsu, ... Microbiome 10 (1), 200, 2022 | 17 | 2022 |
| Microbial sensing by intestinal myeloid cells controls carcinogenesis and epithelial differentiation N Miyata, LL Morris, Q Chen, C Thorne, A Singla, W Zhu, M Winter, ... Cell reports 24 (9), 2342-2355, 2018 | 17 | 2018 |
| How drug shortages affect clinical care: the case of the surgical anesthetic propofol B Romito, J Stone, N Ning, C Yin, EM Llano, J Liu, K Somanath, CT Lee, ... Hospital pharmacy 50 (9), 798-805, 2015 | 13 | 2015 |
| Endoscopic ultrasound acquired portal venous circulating tumor cells predict progression free survival and overall survival in patients with pancreaticobiliary cancers CG Chapman, F Ayoub, E Swei, EM Llano, B Li, UD Siddiqui, I Waxman Pancreatology 20 (8), 1747-1754, 2020 | 9 | 2020 |
| Small-bowel imaging with CT and MRI: overview of techniques and indications JG Fletcher, JL Fidler, JE Huprich, E Llano, G Spencer, DH Bruining Applied Radiology 41 (12), 18, 2012 | 9 | 2012 |
| Favorable outcomes combining vedolizumab with other biologics or tofacitinib for treatment of inflammatory bowel disease EM Llano, S Shrestha, E Burstein, M Boktor, DI Fudman Crohn's & Colitis 360 3 (3), otab030, 2021 | 8 | 2021 |
| Comparative safety of biologic agents in patients with inflammatory bowel disease with active or recent malignancy: a multi-center cohort study AK Holmer, J Luo, KB Russ, S Park, JY Yang, F Ertem, J Dueker, ... Clinical Gastroenterology and Hepatology 21 (6), 1598-1606. e5, 2023 | 7* | 2023 |
| Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis. Microbiome 10: 200 SJ Taylor, MG Winter, CC Gillis, L Silva, AL Dobbins, MK Muramatsu, ... s4 0168-022-01389-7, 2022 | 6 | 2022 |
| Obscure GI bleeding: the role of multiphase CT enterography JE Huprich, JG Fletcher, JL Fidler, E Llano Applied Radiology 40 (12), 16, 2011 | 4 | 2011 |
| Tumor loss-of-function mutations in STK11/LKB1 induce cachexia P Iyengar, AY Gandhi, J Granados, T Guo, A Gupta, J Yu, EM Llano, ... JCI insight 8 (8), 2023 | 3 | 2023 |
| Su450 effectiveness and safety of combining biologics and/or small molecules in inflammatory bowel diseases: systematic review with meta-analysis QA Alayo, M Fenster, O Altayar, K Glassner, EM Llano, A Patel, A Yarur, ... Gastroenterology 160 (6), S-696, 2021 | 3 | 2021 |
| Safety and effectiveness of combining biologics and small molecules in IBD: systematic review with meta-analysis QA Alayo, M Fenster, O Altayar, KL Glassner, E Llano, K Clark-Snustad, ... | 1 | 2021 |
| S0795 Outcomes Combining Vedolizumab With Other Biologics or With Tofacitinib to Treat Inflammatory Bowel Disease EM Llano, S Shrestha, M Boktor, DI Fudman Official journal of the American College of Gastroenterology| ACG 115, S407, 2020 | 1 | 2020 |
